Abstract:Key PointsNMDA receptors (NMDARs) are ion channels gated by the excitatory neurotransmitter glutamate. NMDARs are widespread in the CNS and are essential mediators of synaptic transmission and plasticity.NMDARs exist as multiple subtypes that differ in their molecular (subunit) composition. There are assembled as tetramers composed of two obligatory GluN1 subunits along with two GluN2 or GluN3 subunits, of which there are four (GluN2A–GluN2D) and two subtypes (GluN3A and GluN3B) respectively.Each subunit has a typical modular architecture with two large clamshell-like extracellular domains (the N-terminal domain (NTD) involved in assembly and channel modulation and the agonist-binding domain (ABD)), a transmembrane domain (TMD) and a C-terminal domain (CTD) involved in receptor trafficking and signalling. The NTD and CTD regions are the most divergent and account for much of the functional diversity of NMDARs.Each subunit endows the receptor with distinct biophysical, pharmacological and signalling propertiesThe large extracellular region of the receptor harbours an array of binding sites for small-molecule ligands acting as endogenous or exogenous allosteric modulators. Several of these modulators display strong subunit-selectivity, thus allowing for pharmacological profiling of receptor subunit composition.NMDAR subunit composition is plastic, changing during development and according to neuronal activity. Long-term synaptic plasticity of NMDARs also occurs at mature (adult) synapses and has profound consequences on cell firing and subsequent plasticity.Whether specific receptor subtypes carry out specific tasks in the CNS remains a much debated and challenging issue. In particular, evidence points to tri-heteromeric GluN1/GluN2A/GluN2B receptors as critically involved in 'classical' LTP induction at adult CA3–CA1 synapses.NMDARs are implicated in various neurological and psychiatric conditions. Both hypo- and hyperfunction of NMDAR subpopulations can be deleterious, and there is vivid interest in targeting specific subunits for therapeutic interventions.

GluN3A NMDA receptor subunits: more enigmatic than ever?

GluN3A subunit tunes NMDA receptor synaptic trafficking and content during postnatal brain development

The Roles of GluN3-containing N-methyl-D-aspartate Receptor in Central Nerve System.

Distinct structure and gating mechanism in diverse NMDA receptors with GluN2C and GluN2D subunits

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

Unmasking GluN1/GluN3A excitatory glycine NMDA receptors

GluN2B-containing NMDARs in the mammalian brain: pharmacology, physiology, and pathology

GluN3A and Excitatory Glycine Receptors in the Adult Hippocampus

GluN3A excitatory glycine receptors control adult cortical and amygdalar circuits

Structure, function, and allosteric modulation of NMDA receptors

Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo.

Excitatory GluN1/GluN3A glycine receptors (eGlyRs) in brain signaling

GluN2A- and GluN2B-containing pre-synaptic N-methyl-d-aspartate receptors differentially regulate action potential-evoked Ca2+ influx via modulation of SK channels

ACTIVITY-DEPENDENT INTERNALIZATION OF GLUN2B-CONTAINING NMDARS IS REQUIRED FOR SYNAPTIC INCORPORATION OF GLUN2A AND SYNAPTIC PLASTICITY

Structure and function of GluN1-3A NMDA receptor excitatory glycine receptor channel

The differences between GluN2A and GluN2B signaling in the brain

Circuit-specific control of the medial entorhinal inputs to the dentate gyrus by atypical presynaptic NMDARs activated by astrocytes

N-Glycosylation Regulates the Trafficking and Surface Mobility of GluN3A-Containing NMDA Receptors

GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases

GluN2A Versus GluN2B: Twins, but Quite Different